ipilimumab,nivolumab
bms
[]
continued clinical benefit of #nivolumab + chemo in checkmate 648 at 29 months follow up in 1l #esophageal (escc). #gi23 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how healthcare professionals connect and stay up-to-date on the latest advancements